Cargando…

Chronic kidney disease and gut microbiota

Chronic kidney disease (CKD) refers to a range of various pathophysiological processes correlated with abnormal renal function and a progressive loss in GFR. Just as dysbiosis and altered pathology of the gut are accompanied with hypertension, which is a significant CKD risk factor. Gut dysbiosis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amini Khiabani, Siamak, Asgharzadeh, Mohammad, Samadi Kafil, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440536/ https://www.ncbi.nlm.nih.gov/pubmed/37609403 http://dx.doi.org/10.1016/j.heliyon.2023.e18991

Ejemplares similares

Diversity of Bacteroidaceae family in gut microbiota of patients with chronic kidney disease and end stage renal disease
por: Amini Khiabani, Siamak, et al.
Publicado: (2023)

COVID‐19 reinfection in a healthcare worker after exposure with high dose of virus: A case report
por: Ahmadian, Shahram, et al.
Publicado: (2021)

Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases
por: Bafandeh, Soheila, et al.
Publicado: (2023)

Persistent infection with metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation
por: Leylabadlo, Hamed Ebrahimzadeh, et al.
Publicado: (2016)

Pulmonary Tuberculosis Diagnosis: Where We Are?
por: Leylabadlo, Hamed Ebrahimzadeh, et al.
Publicado: (2016)

Dissemination of carbapenemases producing Gram negative bacteria in the Middle East
por: Zahedi bialvaei, Abed, et al.
Publicado: (2015)

COVID-19, HIV, and Cryptococcal Meningitis Coinfections with Abnormal Laboratory Findings
por: Aghamali, Mina, et al.
Publicado: (2023)

Why the COVID-19 Is Not Significantly Reduced in Iran?
por: Asgharzadeh, Mohammad, et al.
Publicado: (2021)

Effective factors in controlling diabetes progression among patients in the northwest of Iran
por: Asgharzadeh, Mohammad, et al.
Publicado: (2016)

Antibacterial Properties of Aloe vera on Intracanal Medicaments against Enterococcus faecalis Biofilm at Different Stages of Development
por: Ghasemi, Negin, et al.
Publicado: (2020)

Corrigendum to “Antibacterial Properties of Aloe vera on Intracanal Medicaments against Enterococcus faecalis Biofilm at Different Stages of Development”
por: Ghasemi, Negin, et al.
Publicado: (2021)

CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals
por: Bialvaei, Abed Zahedi, et al.
Publicado: (2016)

Homeostasis in the Gut Microbiota in Chronic Kidney Disease
por: Bhargava, Shruti, et al.
Publicado: (2022)

Role of Immigration in Tuberculosis Transmission to Iran: A Systematic Review
por: Mohammadzadeh, Amir, et al.
Publicado: (2020)

Relationship of biofilm formation and different virulence genes in uropathogenic Escherichia coli isolates from Northwest Iran
por: Fattahi, Sargol, et al.
Publicado: (2015)

Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance
por: Abdi, Seyyed Naser, et al.
Publicado: (2020)

The clinical impact of gut microbiota in chronic kidney disease
por: Kim, So Mi, et al.
Publicado: (2020)

EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCING GRAM NEGATIVE BACTERIA IN IRAN: A REVIEW
por: Leylabadlo, Hamed Ebrahimzadeh, et al.
Publicado: (2017)

Molecular Diversity of Mycobacterium tuberculosis Strains in Northwestern Iran
por: Pourostadi, Mahya, et al.
Publicado: (2016)

Tuberculosis Control and Role of Molecular Epidemiology Studies in Iran: A Systematic Review
por: Pourostadi, Mahya, et al.
Publicado: (2017)

The Prevalence of CTX-M-15 Extended-spectrum β-Lactamases Among Salmonella spp. and Shigella spp. Isolated from three Iranian Hospitals
por: Bialvaei, Abed Zahedi, et al.
Publicado: (2017)

A Comprehensive Study on the Antimicrobial Properties of Resveratrol as an Alternative Therapy
por: Abedini, Ehsan, et al.
Publicado: (2021)

Gut Microbiota and the Ways to Correct it in Chronic Kidney Disease
por: Sturov, Nikolay V., et al.
Publicado: (2023)

The profile of key gut microbiota members and short-chain fatty acids in patients with sepsis
por: Nabizadeh, Edris, et al.
Publicado: (2023)

Current Advances in DNA Methylation Analysis Methods
por: Khodadadi, Ehsan, et al.
Publicado: (2021)

Frequency of Smear-Negative Tuberculosis in Northwest Iran
por: Pourostadi, Mahya, et al.
Publicado: (2018)

SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
por: Fathizadeh, Hadis, et al.
Publicado: (2021)

Role of Molecular Epidemiology on Tuberculosis Control in the Middle East Countries: a Systematic Review and Meta-Analysis
por: Pourostadi, Mahya, et al.
Publicado: (2018)

Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
por: Hsu, Chien-Ning, et al.
Publicado: (2022)

Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran
por: Azimi, Somayeh, et al.
Publicado: (2016)

Molecular mechanisms related to colistin resistance in Enterobacteriaceae
por: Aghapour, Zahra, et al.
Publicado: (2019)

Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease
por: Mafra, Denise, et al.
Publicado: (2019)

Gut microbiota and inflammation in chronic kidney disease patients
por: Mafra, Denise, et al.
Publicado: (2015)

The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
por: Chi, Mingxuan, et al.
Publicado: (2021)

Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease
por: Rodrigues, Fernanda G., et al.
Publicado: (2021)

A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects
por: Mertowska, Paulina, et al.
Publicado: (2021)

Alteration of the gut microbiota in Chinese population with chronic kidney disease
por: Jiang, Shuanghong, et al.
Publicado: (2017)

The Association between Gut Microbiota and Uremia of Chronic Kidney Disease
por: Kim, Ji Eun, et al.
Publicado: (2020)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review
por: Martín-del-Campo, Fabiola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hsmv22dqqvd0jf1tk0f8i1gpqg